What is David Raynor’s Ardent Health (ARDT) share ownership after these transactions?

After the reported grant and tax-withholding entries, David Raynor directly owned 130,445 shares of Ardent Health common stock. This post-transaction holding reflects his updated equity position following the restricted stock unit award and associated tax withholding.

Ardent Health (ARDT) SVP awarded 11,538 shares; 1,743 withheld for taxes

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Ardent Health, Inc. senior vice president and chief accounting officer David Raynor reported routine equity compensation activity in the company’s stock. On April 1, 2026 he received a grant of 11,538 shares of common stock at no cost, tied to restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to his continued service. To cover taxes owed on RSU vesting, 924 shares were withheld on April 1, 2026 at $8.67 per share and 819 shares were withheld on March 31, 2026 at $8.56 per share, consistent with Rule 16b-3 treatment rather than open‑market sales. Following these transactions, Raynor directly owned 130,445 shares of Ardent Health common stock.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Byers David Raynor

Role SVP & Chief Accounting Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	924	$8.67	$8K
Grant/Award	Common Stock	11,538	$0.00	--
Tax Withholding	Common Stock	819	$8.56	$7K

Holdings After Transaction: Common Stock — 118,907 shares (Direct)

Footnotes (1)

Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Represents the closing price of the common stock of the Issuer on March 31, 2026. Represents the closing price of the common stock of the Issuer on April 1, 2026. Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date

Key Figures

Stock grant: 11,538 shares Tax withholding shares: 1,743 shares Tax withholding March 31: 819 shares at $8.56 +3 more

6 metrics

Stock grant 11,538 shares Common stock awarded at $0.00 per share on April 1, 2026

Tax withholding shares 1,743 shares Total shares withheld for RSU tax obligations

Tax withholding March 31 819 shares at $8.56 Shares withheld on March 31, 2026

Tax withholding April 1 924 shares at $8.67 Shares withheld on April 1, 2026

Post-transaction holdings 130,445 shares Common stock directly owned after reported transactions

RSU vesting schedule 3 installments Vests in three substantially equal annual installments from April 1, 2026

Key Terms

restricted stock units, Rule 16b-3, tax-withholding disposition, grant, award, or other acquisition, +1 more

5 terms

restricted stock units financial

"Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 16b-3 regulatory

"Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3."

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" for code F transactions."

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition" for the A-coded entry."

continued service financial

"subject to the Reporting Person's continued service with the Issuer through each applicable vesting date"

Form 4 Insider Transactions: What Each Field Means →

04/02/2026 - 04:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Byers David Raynor

(Last)

(First)

(Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD

TENNESSEE

37027

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP & Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/31/2026		F		819⁽¹⁾	D	$8.56⁽²⁾	119,831	D
Common Stock	04/01/2026		F		924⁽¹⁾	D	$8.67⁽³⁾	118,907	D
Common Stock	04/01/2026		A		11,538⁽⁴⁾	A	$0	130,445	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

2. Represents the closing price of the common stock of the Issuer on March 31, 2026.

3. Represents the closing price of the common stock of the Issuer on April 1, 2026.

4. Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did ARDT executive David Raynor report in this Form 4 filing?

David Raynor reported a routine equity compensation grant and related tax withholding. He received 11,538 shares of Ardent Health common stock and had 1,743 shares withheld to cover taxes on restricted stock unit vesting under Rule 16b-3.

How many Ardent Health (ARDT) shares did David Raynor receive?

David Raynor received 11,538 shares of Ardent Health common stock at a price of $0.00 per share. The grant represents restricted stock units scheduled to vest in three substantially equal annual installments beginning April 1, 2026, subject to his continued service.

Were David Raynor’s ARDT transactions open-market buys or sales?

The reported transactions were not open-market trades. They reflect a stock grant and shares withheld to pay taxes on restricted stock unit vesting, coded as grant/award (A) and tax-withholding disposition (F), rather than discretionary purchases or sales in the market.

How many Ardent Health shares were withheld for David Raynor’s taxes?

A total of 1,743 Ardent Health shares were withheld for taxes tied to RSU vesting. This included 819 shares at $8.56 per share on March 31, 2026, and 924 shares at $8.67 per share on April 1, 2026, under Rule 16b-3.

How do David Raynor’s new restricted stock units in ARDT vest over time?

The restricted stock units represented by the 11,538-share grant vest in three substantially equal installments. Vesting occurs on each anniversary of April 1, 2026, and is conditioned on David Raynor’s continued service with Ardent Health through each applicable vesting date.